First Trust Advisors LP Neogenomics Inc Transaction History
First Trust Advisors LP
- $108 Billion
- Q4 2024
A detailed history of First Trust Advisors LP transactions in Neogenomics Inc stock. As of the latest transaction made, First Trust Advisors LP holds 132,180 shares of NEO stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
132,180
Previous 31,705
316.91%
Holding current value
$1.57 Million
Previous $467,000
366.38%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$233 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$169 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$77.4 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$73.1 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$73 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.49B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...